| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |